Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis? - Wikidata - awgldk - TriplyDB

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

http://www.wikidata.org/entity/Q53225040

about

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

http://www.wikidata.org/entity/Q53225040

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@en

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@nl

type

label

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@en

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@nl

prefLabel

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@en

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@nl

P1433

Q53225040-D64A667C-FC39-4045-A676-7789D06E4E4D

P1476

Q53225040-9D7C0078-771B-4B41-B91A-689E463CF32F

P2093

Q53225040-004396C9-223F-409D-ABAC-409090342671

Q53225040-5F0E0A23-C3D6-4E35-A865-02CDB8956E9D

Q53225040-7253EB51-7ABC-4E9E-AF4A-57EB76AC9444

Q53225040-82AB44FB-E1AE-4B6E-944E-238D6D9D0B94

Q53225040-A9D4AF29-EF4C-44E5-ABEB-042ED86307A2

Q53225040-ADD1FD59-CC6F-41A3-84BD-EA2E26B6896E

Q53225040-AF8EDA06-A75F-4BA9-BF75-BDCB105A462D

Q53225040-B83C0A9B-DBA4-43B1-BF55-A276F4F6E6C4

Q53225040-DBCEDA33-92E2-4AE7-8376-5BC335039BFB

P2860

Q53225040-07E6F630-F2B3-4F86-9232-36C0068C2EBE

Q53225040-2E5B550D-73B2-4E67-B613-BEA41B187325

Q53225040-426CAC7E-4B00-4137-925A-189D52152755

Q53225040-52A49539-B5E9-4BE9-86BC-991FBBE1A834

Q53225040-597BC502-D529-4682-B605-341DBF6515BC

Q53225040-5E754540-5DA7-498A-86A6-A902ACAE3269

Q53225040-5EFE2554-1F5C-4C4B-B8E8-3DD6E7D731D4

Q53225040-63E9A807-8C82-4200-B1DC-D57011D20023

Q53225040-6AE5C8D4-6035-4600-992D-275BADBBD9AD

Q53225040-722B4E64-1D19-4F14-8F5D-C02D90B78766

P304

Q53225040-F4057283-215B-4860-940E-DF69772BA237

P31

Q53225040-9B448D37-A999-4B11-B0A3-5A65C11D9C38

P356

Q53225040-661E32EC-A277-4914-B5E0-FBB0B8C47652

P433

Q53225040-A705DD28-4611-425E-A8AE-B9E94C327522

P478

Q53225040-2ED4F9C9-05AB-4E7A-BEB9-AA79B69ABBF4

P50

Q53225040-75CF618F-D2B5-482E-89E2-18188BB44DCF

Q53225040-79F427B5-B794-4290-8F7F-948C6FB0D42E

P577

Q53225040-11545C7F-A4BB-4498-B642-099F7A607181

P698

Q53225040-8F3D3A7E-2E03-4B3C-A1EA-06E3E5AF535A

P356

P1433

Cerebrovascular Diseases

P1476

Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?

@en

P2093

Aline Berthomet

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Neau

http://www.w3.org/2001/XMLSchema#string

Julia Prigent

http://www.w3.org/2001/XMLSchema#string

Mathieu Puyade

http://www.w3.org/2001/XMLSchema#string

Matthias Lamy

http://www.w3.org/2001/XMLSchema#string

Paola Palazzo

http://www.w3.org/2001/XMLSchema#string

Paul Cantagrel

http://www.w3.org/2001/XMLSchema#string

Pierre Agius

http://www.w3.org/2001/XMLSchema#string

Pierre Ingrand

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombosis of the cerebral veins and sinuses

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

A gain-of-function mutation of JAK2 in myeloproliferative disorders

EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Thrombohemorrhagic complications of myeloproliferative disorders.

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

Cerebral venous thrombosis: an update.

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.

Multiparametric Magnetic Resonance Imaging for Prediction of Parenchymal Hemorrhage in Acute Ischemic Stroke After Reperfusion Therapy.

P304

97-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000471891

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

French EGEA study

P577

2017-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28609766

http://www.w3.org/2001/XMLSchema#string